NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Sees Large Increase in Short Interest

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) was the recipient of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 112,100 shares, an increase of 26.0% from the February 28th total of 89,000 shares. Approximately 2.7% of the company’s shares are sold short. Based on an average daily trading volume, of 226,500 shares, the days-to-cover ratio is presently 0.5 days.

NovaBay Pharmaceuticals Trading Down 2.2 %

Shares of NovaBay Pharmaceuticals stock opened at $0.57 on Thursday. The firm has a market capitalization of $2.41 million, a PE ratio of -0.06 and a beta of 2.82. NovaBay Pharmaceuticals has a 52 week low of $0.36 and a 52 week high of $9.08.

NovaBay Pharmaceuticals Company Profile

NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.